TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter
Novel Design of Chocolate is Aimed at Improving Patient Outcomes PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ — TriReme Medical, Inc.
Pioneering Medical Innovations
Novel Design of Chocolate is Aimed at Improving Patient Outcomes PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ — TriReme Medical, Inc.
December 6, 2011 – Claret Medical presents at the Canaccord Cardiovascular Conference in San Francisco.
November 11, 2011 – Claret Medical participates in a live-case transmission for the Transcatheter Cardiovascular Therapeutics (TCT) conference in San
October 28, 2011 – Claret Medical announces the CE Mark approval of MontageTM, a new embolic protection system to address
Mountain View, California (September 28, 2011) – AccessClosure, Inc., a leading manufacturer of extravascular closure devices, announced today the shipment
September 22, 2011 – Claret Medical participates in multiple live-case demonstrations in at Hamburg, Germany with Professor Carl-Heinz Kuck, M.D.
August 17, 2011 – Claret Medical receives CE Mark approval for it’s CE Pro System, the company’s first ever dual
Growth of Mynx Device Continues in International Markets Mountain View, California (May 17, 2011) – AccessClosure, Inc., the market segment
Agreement creates opportunity for improving outcomes in radiation oncology PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ —
PLEASANTON, Calif., May 9, 2011 /PRNewswire/ — TriReme Medical, Inc. (TriReme), a leading developer of innovative catheters and stents for